These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

495 related articles for article (PubMed ID: 33365294)

  • 1. Drug Utilization and Drug Pricing in the Private Primary Healthcare System in Malaysia: An Employer Price Control Mechanism.
    Zin CS; Taufek NH; Bux SH
    Front Public Health; 2020; 8():551328. PubMed ID: 33365294
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Trends in the Cost of Medicines, Consultation Fees and Clinic Visits in Malaysia's Private Primary Healthcare System: Employer Health Insurance Coverage.
    Zin CS; Ab Rahman NS; Mohamed Nazar NI; Kurdi A; Godman B
    J Multidiscip Healthc; 2023; 16():1683-1697. PubMed ID: 37350986
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Five-year examination of utilization and drug cost outcomes associated with benefit design changes including reference pricing for proton pump inhibitors in a state employee health plan.
    Johnson JT; Neill KK; Davis DA
    J Manag Care Pharm; 2011 Apr; 17(3):200-12. PubMed ID: 21434697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Physician and Patient Adjustment to Reference Pricing for Drugs.
    Robinson JC; Whaley C; Brown TT; Dhruva SS
    JAMA Netw Open; 2020 Feb; 3(2):e1920544. PubMed ID: 32022881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical policies: effects of reference pricing, other pricing, and purchasing policies.
    Acosta A; Ciapponi A; Aaserud M; Vietto V; Austvoll-Dahlgren A; Kösters JP; Vacca C; Machado M; Diaz Ayala DH; Oxman AD
    Cochrane Database Syst Rev; 2014 Oct; 2014(10):CD005979. PubMed ID: 25318966
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Community pharmacy and mail order cost and utilization for 90-day maintenance medication prescriptions.
    Khandelwal N; Duncan I; Rubinstein E; Ahmed T; Pegus C
    J Manag Care Pharm; 2012 Apr; 18(3):247-55. PubMed ID: 22468733
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of innovation and insurance coverage on price elasticity of demand for prescription drugs: some empirical lessons in pharmacoeconomics.
    Mendoza RL
    J Med Econ; 2020 Sep; 23(9):915-922. PubMed ID: 32432950
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of Reference Pricing for Diagnostic Laboratory Testing With Changes in Patient Choices, Prices, and Total Spending for Diagnostic Tests.
    Robinson JC; Whaley C; Brown TT
    JAMA Intern Med; 2016 Sep; 176(9):1353-9. PubMed ID: 27454826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of alternative pricing methods for drugs in California Workers' Compensation System: Fee-schedule pricing.
    Wilson L; Turkistani FA; Huang W; Tran DM; Lin TK
    PLoS One; 2018; 13(5):e0197449. PubMed ID: 29799850
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evidence-based decision on medical technologies in Asia Pacific: experiences from India, Malaysia, Philippines, and Pakistan.
    Thatte U; Hussain S; de Rosas-Valera M; Malik MA
    Value Health; 2009; 12 Suppl 3():S18-25. PubMed ID: 20586975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Financial Impact of Alternative Pricing Benchmarks for Physician-Dispensed Drugs in the California Workers' Compensation System.
    Wilson L; Turkistani F; Tran DM; Huang W; Lin TK
    Appl Health Econ Health Policy; 2019 Apr; 17(2):231-242. PubMed ID: 30484140
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Reference Pricing, Consumer Cost-Sharing, and Insurer Spending for Advanced Imaging Tests.
    Robinson JC; Whaley C; Brown TT
    Med Care; 2016 Dec; 54(12):1050-1055. PubMed ID: 27479594
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pricing Treatments Cost-Effectively when They Have Multiple Indications: Not Just a Simple Threshold Analysis.
    Goldhaber-Fiebert JD; Cipriano LE
    Med Decis Making; 2023; 43(7-8):914-929. PubMed ID: 37698120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Reference Pricing with Drug Selection and Spending.
    Robinson JC; Whaley CM; Brown TT
    N Engl J Med; 2017 Aug; 377(7):658-665. PubMed ID: 28813219
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association between availability of health service prices and payments for these services.
    Whaley C; Schneider Chafen J; Pinkard S; Kellerman G; Bravata D; Kocher R; Sood N
    JAMA; 2014 Oct 22-29; 312(16):1670-6. PubMed ID: 25335149
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drug Expenditure, Price, and Utilization in the U.S. Medicaid: A Trend Analysis for SSRI and SNRI Antidepressants from 1991 to 2018.
    Alrasheed M; Hincapie AL; Guo JJ
    J Ment Health Policy Econ; 2021 Mar; 24(1):3-11. PubMed ID: 33739932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prescription Drug Utilization and Reimbursement Increased Following State Medicaid Expansion in 2014.
    Mahendraratnam N; Dusetzina SB; Farley JF
    J Manag Care Spec Pharm; 2017 Mar; 23(3):355-363. PubMed ID: 28230452
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Changes in Drug List Prices and Amounts Paid by Patients and Insurers.
    Yang EJ; Galan E; Thombley R; Lin A; Seo J; Tseng CW; Resneck JS; Bach PB; Dudley RA
    JAMA Netw Open; 2020 Dec; 3(12):e2028510. PubMed ID: 33295971
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increases in consumer cost sharing redirect patient volumes and reduce hospital prices for orthopedic surgery.
    Robinson JC; Brown TT
    Health Aff (Millwood); 2013 Aug; 32(8):1392-7. PubMed ID: 23918483
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of privatization of the drug distribution system on drug prices in Malaysia.
    Babar ZD; Izham MI
    Public Health; 2009 Aug; 123(8):523-33. PubMed ID: 19665741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.